Evidence for anticipation and association of deletion size with severity in facioscapulohumeral muscular systrophy

Annals of Neurology

Volumn 39, Issue 6, 1996, Pages 744-748

  Tawil, Rabi ^a,d   Forrester, James ^a   Griggs, Robert C ^a   Mendell, Jerry ^b   Kissel, John ^b   McDermott, Michael ^a   King, Wendy ^b   Weiffenbach, Barbara ^c   Figlewicz, Denise ^a   Cos, Lynn ^e   Langsam, Ariann ^e   Pandya, Shree ^e   Martens, Bill ^e   Brower, Christine ^e   Herr, Barbara ^e   Downing, Karen ^b  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c GENOME THERAPEUTICS CORPORATION   (United States)

^d UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^e UNIVERSITY OF ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICIPATION; ARTICLE; DISEASE ASSOCIATION; DISEASE SEVERITY; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; GENE DELETION; GENE EXPRESSION; GENE LOCATION; GENETIC HETEROGENEITY; GENOTYPE; HUMAN; HUMAN TISSUE; PHENOTYPE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; BLOTTING, SOUTHERN; CHROMOSOMES, HUMAN, PAIR 4; FEMALE; GENE DELETION; GENOTYPE; HUMANS; MALE; MUSCULAR DYSTROPHIES; PHENOTYPE; POINT MUTATION; SEVERITY OF ILLNESS INDEX;

EID: 0029984970     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410390610     Document Type: Article

References (20)

1. Padberg GW. Facioscapulohumeral disease. Thesis, University of Leiden, The Netherlands, 1982
2. Padberg GW, Frants RR, Brouwer OF, et al. Facioscapulohumeral muscular dystrophy in the Dutch population. Muscle Nerve 1995;(suppl 2):S81-S84
3. Wijmenga C, Frants RR, Brouwer OF, et al. Location of facioscapulohumeral muscular dystrophy on chromosome 4. Lancet 1990;336:651-653
4. Sarfarazi M, Wijmenga C, Upadhyaya M, et al. Regional mapping of the facioscapulohumeral disease on 4q35: combined analysis of an international consortium. Am J Hum Genet 1992;51:396-403
5. Wijmenga C, Hewitt JE, Sandkuijl LA, et al. Chromosome 4 DNA rearrangement associated with facioscapulohumeral muscular dystrophy. Nature Genet 1992;2:26-30
6. Van Deutekom JCT, Wijmenga C, Van Tienhoven EAE, et al. FSHD associated DNA rearrangements are due to large deletions of integral copies of a 3.2 Kb tandemly repeated unit. Hum Mol Genet 1993;2:2037-2042
7. Weiffenbach B, Dubois J, Storvick D, et al. Mapping of the facioscapulohumeral dystrophy gene is complicated by chromosome 4q35 recombination. Nature Genet 1993;4:165-169
8. Upadhyaya M, Jardine P, Maynard J, et al. Molecular analysis of British facioscapulohumeral dystrophy families for 4q DNA rearrangements. Hum Mol Genet 1993;2:981-987
9. Hewitt JE, Lyle R, Clark LN, et al. Analysis of the tandem repeat locus D4Z4 associated with facioscapulohumeral muscular dystrophy. Hum Mol Genet 1994;3:1287-1295
10. Winokur ST, Bengtsson U, Feddersen J, et al. The DNA rearrangement associated with facioscapulohumeral muscular dystrophy involves a heterochromatin-associated repetitive element: implications for a role of chromatin structure in the pathogenesis of the disease. Chromosome Res 1994;2:225-234
11. Tawil R, McDermott MP, Mendell JR, et al. Facioscapulohumeral dystrophy (FSHD): design of natural history study and results of baseline testing. Neurology 1994;44:442-446
12. Tawil R, McDermott MP, Mendell JR, et al. Facioscapulohumeral muscular dystrophy (FSHD): design of natural history study and results of baseline testing. Neurology 1994;44:442-446
13. Alford RL, Hammond HA, Coto I, Caskey CT. Rapid and efficient resolution of parentage by amplification of short tandem repeats. Am J Hum Genet 1994;55:190-195
14. Personius KE, Pandya S, King WM, et al. FSH dystrophy natural history study: standardization of testing procedure and reliability of measurements. Phys Ther 1994;74:253-263
15. Jardine PE, Koch MC, Lunt PW, et al. De novo facioscapulohumeral muscular dystrophy defined by DNA probe p13E-11 (D4F104S1). Arch Dis Child 1994;71:221-227
16. Lunt PW, Jardine PE, Koch MC, et al. Correlation between fragment size at D4F104S1 and age of onset or at wheelchair use, with possible generational effect, accounts for much phenotypic variation in 4q35-facioscapulohumeral muscular dystrophy (FSHD). Hum Mol Genet 1995;4:951-958
17. Katz M, Suely MK, Passos-Bueno MR, et al. High proportion of new mutation and possible anticipation in Brazilian facioscapulohumeral muscular dystrophy families. Am J Hum Genet 1995;56:99-105
18. Goto K, Lee JH, Matsuda C, et al. DNA rearrangements in Japanese facioscapulohumeral muscular dystrophy patients: clinical correlations. Neuromusc Dis 1995;5:201-208
19. La Spada AR, Paulson HL, Fischbeck KH. Trinucleotide repeat expansion in neurological disease. Ann Neurol 1994;36: 814-822
20. Hall JG. How imprinting is relevant to human disease. Development 1990(suppl):141-148